Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis.

Publication Year: 2022

DOI:
10.1002/ppul.25840

PMCID:
PMC9305469

PMID:
35084122

Journal Information

Full Title: Pediatr Pulmonol

Abbreviation: Pediatr Pulmonol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTERESTS The authors do not have any financial and personal relationships with other people or organizations that could inappropriately influence (bias) this study."

Evidence found in paper:

"The authors would like to acknowledge the persons with CF, care providers, and clinic coordinators at our CF center, as well as the inpatient team who provided care for the patients during these hospitalizations. The authors would also like to acknowledge Emily Ansusinha who abstracts the initial clinical data for the data repository. This study did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors. Dr. Hahn was funded by the CF Foundation for a career development award during the project period (Harry Schwachman Clinical Investigator Award HAHN18A0‐Q)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025